表 4. Global research hotspots on oncology: respiratory system and breast cancer.
肿瘤领域全球研究热点——呼吸系统与乳腺肿瘤
研究主题 | 相关研究 | 被引次数
查询时间 2020.09.23 |
期刊来源 |
呼吸系统肿瘤 | |||
临床试验 | Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer:results from the CA209-003 study[27] | 204 | J Clin Oncol |
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma(KEYNOTE-028):preliminary results from a non-randomised,open-label,phase 1b trial[28] | 195 | Lancet Oncol | |
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA(N1-N2) EGFR-mutant NSCLC(ADJUVANT/CTONG1104):a randomised,open-label,phase 3 study[29] | 140 | Lancet Oncol | |
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer(ATLANTIC):an open-label,single-arm,phase 2 study[30] | 170 | Lancet Oncol | |
PD-L1 免疫组化 | Agreement between programmed cell death ligand-1 diagnostic assays across multiple protein expression cutoffs in non-small cell lung cancer[31] | 170 | Clin Cancer Res |
肺癌脑转移预后评估分级 | Estimating survival in patients with lung cancer and brain metastases:an update of the graded prognostic assessment for lung cancer using molecular markers(Lung-molGPA)[32] | 179 | JAMA Oncol |
非小细胞肺癌临床和分子特征 | Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma:
a systematic review and meta-analysis[33] |
134 | JAMA Oncol |
乳腺肿瘤 | |||
乳腺癌 | Effect of axillary dissection vs no axillary dissection on 10-Year overall survival among women with invasive breast cancer and sentinel node metastasis:the ACOSOG Z0011(Alliance) randomized clinical trial[34] | 299 | JAMA |
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer[35] | 447 | N Engl J Med | |
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer[36] | 388 | N Engl J Med | |
Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer[37] | 453 | JAMA | |
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer:a pooled analysis of 3771 patients treated with neoadjuvant therapy[38] | 292 | Lancet Oncol | |
乳房植入物 | Breast implants and the risk of anaplastic large-cell lymphoma in the breast[39] | 109 | JAMA Oncol |